J. Taubenberger and D. Morens, 1918 Influenza: the Mother of All Pandemics, Emerging Infectious Diseases, vol.12, issue.1, pp.15-22, 1918.
DOI : 10.3201/eid1209.05-0979

R. Rappuoli and P. Dormitzer, Influenza: Options to Improve Pandemic Preparation, Science, vol.336, issue.6088, pp.1531-1533, 2012.
DOI : 10.1126/science.1221466

L. Lambert and A. Fauci, Influenza Vaccines for the Future, New England Journal of Medicine, vol.363, issue.21, pp.2036-2044, 2010.
DOI : 10.1056/NEJMra1002842

B. Murphy and M. Clements, The Systemic and Mucosal Immune Response of Humans to Influenza A Virus, Curr Top Microbiol Immunol, vol.146, pp.107-116, 1989.
DOI : 10.1007/978-3-642-74529-4_12

D. Gordon, D. Sajkov, R. Woodman, Y. Honda-okubo, and M. Cox, Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax??? polysaccharide adjuvant, Vaccine, vol.30, issue.36, pp.5407-5416, 2012.
DOI : 10.1016/j.vaccine.2012.06.009

P. Pushko, T. Kort, M. Nathan, M. Pearce, and G. Smith, Recombinant H1N1 virus-like particle vaccine elicits protective immunity in ferrets against the 2009 pandemic H1N1 influenza virus, Vaccine, vol.28, issue.30, pp.4771-4776, 2010.
DOI : 10.1016/j.vaccine.2010.04.093

G. Liu, B. Tarbet, L. Song, L. Reiserova, and B. Weaver, Immunogenicity and Efficacy of Flagellin-Fused Vaccine Candidates Targeting 2009 Pandemic H1N1 Influenza in Mice, PLoS ONE, vol.27, issue.Pt 9, 2011.
DOI : 10.1371/journal.pone.0020928.t002

V. Iyer, M. Liyanage, Y. Shoji, J. Chichester, and R. Jones, Formulation development of a plant-derived h1n1 influenza vaccine containing purified recombinant hemagglutinin antigen, Human Vaccines & Immunotherapeutics, vol.256, issue.4, 2012.
DOI : 10.1016/j.vaccine.2008.03.045

C. Wei, J. Boyington, P. Mctamney, W. Kong, and M. Pearce, Induction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination, Science, vol.329, issue.5995, pp.1060-1064, 2010.
DOI : 10.1126/science.1192517

B. Petsch, M. Schnee, A. Vogel, E. Lange, and B. Hoffmann, Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection, Nature Biotechnology, vol.123, issue.12, 2012.
DOI : 10.1099/vir.0.014480-0

T. Wilkinson, C. Li, C. Chui, A. Huang, and M. Perkins, Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans, Nature Medicine, vol.94, issue.2, pp.274-280, 2012.
DOI : 10.1128/JVI.79.9.5684-5694.2005

J. Mcelhaney, D. Xie, W. Hager, M. Barry, and Y. Wang, T Cell Responses Are Better Correlates of Vaccine Protection in the Elderly, The Journal of Immunology, vol.176, issue.10, pp.6333-6339, 2006.
DOI : 10.4049/jimmunol.176.10.6333

J. Mcelhaney, The unmet need in the elderly: Designing new influenza vaccines for older adults, Vaccine, vol.23, issue.1, pp.10-25, 2005.
DOI : 10.1016/j.vaccine.2005.04.019

B. Arulanandam, J. Mittler, W. Lee, O. Toole, M. Metzger et al., Neonatal Administration of IL-12 Enhances the Protective Efficacy of Antiviral Vaccines, The Journal of Immunology, vol.164, issue.7, pp.3698-3704, 2000.
DOI : 10.4049/jimmunol.164.7.3698

V. Huber, R. Mckeon, M. Brackin, L. Miller, and R. Keating, Distinct Contributions of Vaccine-Induced Immunoglobulin G1 (IgG1) and IgG2a Antibodies to Protective Immunity against Influenza, Clinical and Vaccine Immunology, vol.13, issue.9, pp.981-990, 2006.
DOI : 10.1128/CVI.00156-06

K. Mozdzanowska, M. Furchner, G. Washko, J. Mozdzanowski, and G. W. , A pulmonary influenza virus infection in SCID mice can be cured by treatment with hemagglutinin-specific antibodies that display very low virusneutralizing activity in vitro, J Virol, vol.71, pp.4347-4355, 1997.

G. Spohn, G. Jennings, B. Martina, I. Keller, and M. Beck, A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice, Virology Journal, vol.7, issue.1, pp.146-156, 2010.
DOI : 10.1186/1743-422X-7-146

G. Spohn, R. Guler, P. Johansen, I. Keller, and M. Jacobs, A Virus-Like Particle-Based Vaccine Selectively Targeting Soluble TNF-?? Protects from Arthritis without Inducing Reactivation of Latent Tuberculosis, The Journal of Immunology, vol.178, issue.11, pp.7450-7457, 2007.
DOI : 10.4049/jimmunol.178.11.7450

G. Spohn, I. Keller, M. Beck, P. Grest, and G. Jennings, Active immunization with IL-1 displayed on virus-like particles protects from autoimmune arthritis, European Journal of Immunology, vol.32, issue.3, pp.877-887, 2008.
DOI : 10.1002/eji.200737989

G. Spohn, K. Schwarz, P. Maurer, H. Illges, and N. Rajasekaran, Protection against Osteoporosis by Active Immunization with TRANCE/RANKL Displayed on Virus-Like Particles, The Journal of Immunology, vol.175, issue.9, pp.6211-6218, 2005.
DOI : 10.4049/jimmunol.175.9.6211

T. Röhn, G. Jennings, M. Hernandez, P. Grest, and M. Beck, Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis, European Journal of Immunology, vol.482, issue.11, pp.2857-2867, 2006.
DOI : 10.1002/eji.200636658

M. Bachmann and G. Jennings, Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns, Nature Reviews Immunology, vol.54, issue.11, pp.787-796, 2010.
DOI : 10.1038/nri2868

J. Blander and R. Medzhitov, Toll-dependent selection of microbial antigens for presentation by dendritic cells, Nature, vol.80, issue.7085, pp.808-812, 2006.
DOI : 10.1038/nature04596

L. Reed and H. Muench, A simple method of estimating fifty per cent endpoints, American Journal of Epidemiology, 1938.

N. Svitek, P. Rudd, K. Obojes, S. Pillet, and V. Messling-von, Severe seasonal influenza in ferrets correlates with reduced interferon and increased IL-6 induction, Virology, vol.376, issue.1, pp.53-59, 2008.
DOI : 10.1016/j.virol.2008.02.035

A. Palucka, H. Ueno, J. Connolly, F. Kerneis-norvell, and J. Blanck, Dendritic Cells Loaded With Killed Allogeneic Melanoma Cells can Induce Objective Clinical Responses and MART-1 Specific CD8+ T-cell Immunity, Journal of Immunotherapy, vol.29, issue.5, pp.545-557, 2006.
DOI : 10.1097/01.cji.0000211309.90621.8b

L. Vence, A. Palucka, J. Fay, T. Ito, and Y. Liu, Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma, Proceedings of the National Academy of Sciences, vol.104, issue.52, pp.20884-20889, 2007.
DOI : 10.1073/pnas.0710557105

D. Chujo, E. Foucat, M. Takita, T. Itoh, and K. Sugimoto, Emergence of a Broad Repertoire of GAD65-Specific T-Cells in Type 1 Diabetes Patients With Graft Dysfunction After Allogeneic Islet Transplantation, Cell Transplantation, vol.21, issue.12, 2012.
DOI : 10.3727/096368912X654993

A. Jegerlehner, P. Maurer, J. Bessa, H. Hinton, and M. Kopf, TLR9 Signaling in B Cells Determines Class Switch Recombination to IgG2a, The Journal of Immunology, vol.178, issue.4, pp.2415-2420, 2007.
DOI : 10.4049/jimmunol.178.4.2415

N. Schmitz, R. Beerli, M. Bauer, A. Jegerlehner, and K. Dietmeier, Universal vaccine against influenza virus: Linking TLR signaling to anti-viral protection, European Journal of Immunology, vol.40, issue.S4, pp.863-869, 2012.
DOI : 10.1002/eji.201041225

A. Link, F. Zabel, Y. Schnetzler, A. Titz, and F. Brombacher, Innate Immunity Mediates Follicular Transport of Particulate but Not Soluble Protein Antigen, The Journal of Immunology, vol.188, issue.8, pp.3724-3733, 2012.
DOI : 10.4049/jimmunol.1103312

S. Keller, K. Schwarz, V. Manolova, C. Allmen-von, and M. Kinzler, Innate signaling regulates cross-priming at the level of DC licensing and not antigen presentation, European Journal of Immunology, vol.183, issue.1, pp.103-112, 2010.
DOI : 10.1002/eji.200939559

L. Perrone, A. Ahmad, V. Veguilla, X. Lu, and G. Smith, Intranasal Vaccination with 1918 Influenza Virus-Like Particles Protects Mice and Ferrets from Lethal 1918 and H5N1 Influenza Virus Challenge, Journal of Virology, vol.83, issue.11, pp.5726-5734, 2009.
DOI : 10.1128/JVI.00207-09

B. Baras, L. De-waal, K. Stittelaar, V. Jacob, and S. Giannini, Pandemic H1N1 vaccine requires the use of an adjuvant to protect against challenge in na??ve ferrets, Vaccine, vol.29, issue.11, pp.2120-2126, 2011.
DOI : 10.1016/j.vaccine.2010.12.125

A. Shaw, New technologies for new influenza vaccines, Vaccine, vol.30, issue.33, pp.4927-4933, 2012.
DOI : 10.1016/j.vaccine.2012.04.095

M. Bachmann, U. Rohrer, T. Kündig, K. Bürki, and H. Hengartner, The influence of antigen organization on B cell responsiveness, Science, vol.262, issue.5138, pp.1448-1451, 1993.
DOI : 10.1126/science.8248784

B. Chackerian, D. Lowy, and J. Schiller, Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies, Journal of Clinical Investigation, vol.108, issue.3, pp.415-423, 2001.
DOI : 10.1172/JCI11849

A. Jegerlehner, T. Storni, G. Lipowsky, M. Schmid, and P. Pumpens, Regulation of IgG antibody responses by epitope density and CD21-mediated costimulation, AID-IMMU3305.3.0.CO, pp.3305-3314, 2002.
DOI : 10.1002/1521-4141(200211)32:11<3305::AID-IMMU3305>3.0.CO;2-J

A. Tissot, P. Maurer, J. Nussberger, R. Sabat, and T. Pfister, Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study, The Lancet, vol.371, issue.9615, pp.821-827, 2008.
DOI : 10.1016/S0140-6736(08)60381-5

P. Maurer, G. Jennings, J. Willers, F. Rohner, and Y. Lindman, A therapeutic vaccine for nicotine dependence: preclinical efficacy, and phase I safety and immunogenicity, European Journal of Immunology, vol.143, issue.7, pp.2031-2040, 2005.
DOI : 10.1002/eji.200526285

P. Ambühl, A. Tissot, A. Fulurija, P. Maurer, and J. Nussberger, A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity, Journal of Hypertension, vol.25, issue.1, pp.63-72, 2007.
DOI : 10.1097/HJH.0b013e32800ff5d6

J. Cornuz, S. Zwahlen, W. Jungi, J. Osterwalder, and K. Klingler, A Vaccine against Nicotine for Smoking Cessation: A Randomized Controlled Trial, PLoS ONE, vol.3, issue.6, 2008.
DOI : 10.1371/journal.pone.0002547.s002

T. Kündig, G. Senti, G. Schnetzler, C. Wolf, P. Vavricka et al., Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults, Journal of Allergy and Clinical Immunology, vol.117, issue.6, pp.1470-1476, 2006.
DOI : 10.1016/j.jaci.2006.01.040

B. Winblad, N. Andreasen, L. Minthon, A. Floesser, and G. Imbert, Safety, tolerability, and antibody response of active Ab immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebocontrolled , first-in-human study, Lancet Neurol, vol.1112, pp.597-604, 2012.

T. Guarnaccia, L. Carolan, S. Maurer-stroh, R. Lee, and E. Job, Antigenic Drift of the Pandemic 2009 A(H1N1) Influenza Virus in a Ferret Model, PLoS Pathogens, vol.91, issue.5, 2013.
DOI : 10.1371/journal.ppat.1003354.s004

J. Teijaro, D. Verhoeven, C. Page, D. Turner, and D. Farber, Memory CD4 T Cells Direct Protective Responses to Influenza Virus in the Lungs through Helper-Independent Mechanisms, Journal of Virology, vol.84, issue.18, pp.9217-9226, 2010.
DOI : 10.1128/JVI.01069-10

K. Mckinstry, T. Strutt, Y. Kuang, D. Brown, and S. Sell, Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms, Journal of Clinical Investigation, vol.122, issue.8, pp.2847-2856, 2012.
DOI : 10.1172/JCI63689DS1

S. Seo and R. Webster, Tumor Necrosis Factor Alpha Exerts Powerful Anti-Influenza Virus Effects in Lung Epithelial Cells, Journal of Virology, vol.76, issue.3, pp.1071-1076, 2002.
DOI : 10.1128/JVI.76.3.1071-1076.2002

M. Hocart, J. Mackenzie, and G. Stewart, The Immunoglobulin G Subclass Responses of Mice to Influenza A Virus: the Effect of Mouse Strain, and the Neutralizing Abilities of Individual Protein A-purified Subclass Antibodies, Journal of General Virology, vol.70, issue.9, pp.2439-2448, 1989.
DOI : 10.1099/0022-1317-70-9-2439

E. Govorkova, R. Webby, J. Humberd, J. Seiler, and R. Webster, Immunization with Reverse???Genetics???Produced H5N1 Influenza Vaccine Protects Ferrets against Homologous and Heterologous Challenge, The Journal of Infectious Diseases, vol.194, issue.2, pp.159-167, 2006.
DOI : 10.1086/505225

E. Vela, M. Buccellato, K. Tordoff, G. Stark, and J. Bigger, Efficacy of a heterologous vaccine and adjuvant in ferrets challenged with influenza virus H5N1, Influenza and Other Respiratory Viruses, vol.6, issue.5, 2012.
DOI : 10.1111/j.1750-2659.2011.00321.x

F. Davenport, A. Hennessy, and F. Askin, Lack of adjuvant effect of A1PO4 on purified influenza virus hemagglutinins in man, J Immunol, vol.100, pp.1139-1140, 1968.

J. Bresson, C. Perronne, O. Launay, C. Gerdil, and M. Saville, Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial, The Lancet, vol.367, issue.9523, pp.1657-1664, 1194.
DOI : 10.1016/S0140-6736(06)68656-X

J. Treanor, W. Keitel, and I. Stephenson, Chapter 51: Influenza. New Generation Vaccines, 2009.